IP Library Granted Patent US 8,005,534
Granted Patent B2
US 8,005,534 · App. 11/330,593 · Granted Aug 23, 2011

System and method for prediction of adverse events during treatment of psychological and neurological disorders

Assignee: Nellcor Puritan Bennett LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,005,534
App. No.
11/330,593
Granted
Aug 23, 2011
Kind
B2
Abstract

The present invention is a system and method of deriving and computing features and indices that predict the likelihood of psychological and neurological adverse events such as suicidal thoughts and/or actions. The method of the present invention further predicts the likelihood of suicidal thoughts and/or actions prior to and or during treatment for psychological disease. To obtain such features and indices, power spectrum and time domain values are derived from biopotential signals acquired from the subject being tested. The system and method identify people who are likely to experience changing, especially worsening, symptoms of psychological and neurological adverse events such as suicidal thoughts or actions and who therefore may be at risk (e.g. suicide).

Claims (25)

1. A system for predicting a psychological and neurological adverse event from electroencephalographic (EEG) signals comprising:

a data acquisition unit for acquiring electroencephalographic signals from a subject being evaluated,

a processor for:

computing at least one parameter from said electroencephalographic signals,

deriving a first feature from said at least one parameter at a pre-treatment condition,

deriving a second feature from said at least one parameter after an initiation of treatment of the subject,

creating an index by combining said first feature and said second feature, and

predicting the adverse event through the use of said index,

wherein said treatment is pharmacological treatment, psychotherapy, electroconvulsive therapy, transmagnetic stimulation or neurostimulation and wherein said adverse event is suicidal thoughts, suicidal actions, somatic symptoms, sexual side-effects, nausea or vomiting.

2. The system for predicting a psychological and neurological adverse event from electroencephalographic signals of claim 1 , wherein said index combining said first and second features is a distance from an origin to a point represented by said first and second features.

3. The system for predicting a psychological and neurological adverse event from electroencephalographic signals of claim 1 wherein said at least one parameter is computed using a combination of relative EEG theta power and relative combined theta+alpha asymmetry.

4. The system for predicting a psychological and neurological adverse event from electroencephalographic signals of claim 1 , wherein said first feature and said second feature are relative theta frequency band power.

5. The system for predicting a psychological and neurological adverse event from electroencephalographic signals of claim 1 , wherein said first feature and said second feature are relative theta+alpha frequency band asymmetry.

6. A method of predicting a psychological and neurological adverse event from electroencephalographic (EEG) signals, comprising the steps of:

acquiring electroencephalographic signals from a subject being evaluated,

computing with a processor at least one parameter from said electroencephalographic signals,

deriving a first feature from said at least one parameter at a pre-treatment condition,

deriving a second feature from said at least one parameter after an initiation of treatment of said subject,

creating an index by combining said first feature and said second feature,

predicting the psychological and neurological adverse event through the use of said index, and

wherein said treatment is pharmacological treatment, psychotherapy, electroconvulsive therapy, transmagnetic stimulation or neurostimulation and wherein said adverse event is suicidal thoughts, suicidal actions, somatic symptoms, sexual side-effects, nausea or vomiting.

7. The method of predicting a psychological and neurological adverse event from electroencephalographic signals of claim 6 , wherein said first feature and said second feature are relative theta frequency band power.

8. The method of predicting a psychological and neurological adverse event from electroencephalographic signals of claim 6 , wherein said first feature and said second feature are relative theta+alpha frequency band asymmetry.

9. The method of predicting a psychological and neurological adverse event from electroencephalographic signals of claim 6 , wherein said index combining said first and second features is a distance from an origin to a point represented by said first and second features.

10. The method of predicting a psychological and neurological adverse event from electroencephalographic signals of claim 6 wherein said at least one parameter is computed using a combination of relative EEG theta power and relative combined theta+alpha asymmetry.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2012
From: NELLCOR PURITAN BENNETT LLC
To: COVIDIEN LP
Reel/Frame 029431/0511 →
MERGER Recorded Jan 11, 2010
From: ASPECT MEDICAL SYSTEMS, INC.
To: ASPECT MEDICAL SYSTEMS, LLC
Reel/Frame 023758/0188 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2010
From: ASPECT MEDICAL SYSTEMS, LLC
To: NELLCOR PURITAN BENNETT LLC
Reel/Frame 023761/0698 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2006
From: GREENWALD, SCOTT D.; DEVLIN, PHILIP H.; SIGL, JEFFREY C.
To: ASPECT MEDICAL SYSTEMS, INC.
Reel/Frame 018181/0984 →
Continuity (2)
Provisional Application 60643350 · Jan 12, 2005
Related Publication 20060167370A1 · Jul 27, 2006